Emiko Sakaida

26PUBLICATIONS
118CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 22, 2026
Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

|Feb 14, 2026
Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.

Yu Yagi, Yusuke Kanemasa, Hideki Goto

|Nov 28, 2025
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome.

Motohiko Oshima, Naoya Takayama, Yaeko Nakajima-Takagi

|Sep 15, 2025
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation.

Takayuki Fujii, Masatoshi Sakurai, Hiroaki Shimizu

Pageof 5

Frequent Collaborators

8 joint publications

Yoshiko Atsuta

4 joint publications

Noriko Doki

4 joint publications

Chiaki Nakaseko

4 joint publications

Shingo Yano